Sectoral Asset Management Inc Prometheus Biosciences, Inc. Transaction History

Sectoral Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$103.46 - $126.29 $426,255 - $520,314	-4,120 Reduced 3.67%	108,090 $11.6 Million
Q4 2022 Feb 10, 2023	BUY	$36.06 - $117.21 $324,540 - $1.05 Million	9,000 Added 8.72%	112,210 $12.3 Million
Q3 2022 Nov 10, 2022	SELL	$28.17 - $59.01 $1.95 Million - $4.09 Million	-69,295 Reduced 40.17%	103,210 $6.09 Million
Q2 2022 Aug 15, 2022	BUY	$22.39 - $38.94 $3.86 Million - $6.72 Million	172,505 New	172,505 $4.87 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.